Drug Type Monoclonal antibody |
Synonyms anti-CD148 mAb (Amgen), anti-CD148 mAb (Immunex) |
Target |
Action inhibitors |
Mechanism PTPRJ inhibitors(protein tyrosine phosphatase receptor type J inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | United States | - | |
Neovascularization, Pathologic | Discovery | United States | - |